The global blood flow measurement devices market size was worth USD 447.4 million in 2020. This market is growing CAGR of 9.29 % to reach USD 697.7 million by 2025.
There are constant blood flow volumes in the body that vary with the vitality and needs of the organ. Some blood flow values are 100 to 250 cm/s in the aorta, the abdominal segment contains 100 cm/s blood flow, and the concave vein needs a continuous blood flow of about 5 to 10 cm/s. Blood acts as a food and nutritional support for various organs, and an adequate amount of blood is essential for their proper functioning.
Besides, various diseases and disorders such as hypertension and diabetes can lead to a variation in blood supply to the organs, which, if left untreated, can lead to organ failure. Blood flow measurement can provide vital information that can be analyzed for accurate diagnosis of the diseases.
The significant factors that are boosting the growth of blood flow measurement devices market are Increase in non-communicable diseases is also expected to stimulate market growth. Growing technological developments is also a driving factor for the global market growth.
Entering the unused market and developing clinical applications for blood flow meters is an opportunity for blood flow measuring devices market. The worldwide market for blood flow meters is consolidated, with some key players having the most significant share due to active R&D activities. Players are developing innovative products to capitalize on lucrative opportunities in the Blood Flow Measurement Devices Market.
The major challenge which is limiting the growth of the blood flow measurement devices market is the development of alternative methods for the treatment of cardiovascular diseases.
Market Size Available
2019 – 2025
2020 – 2025
By Product, Application, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, Asia Pacific, Latin America, Middle East and Africa
This research report on the Global Blood Flow Measurement Devices Market has been segmented and sub-segmented based on the product, application and region.
Blood Flow Measurement Devices Market - By Product:
Based on the product, the ultrasound segment has contributed the largest share of the worldwide market for blood flow meters. In 2019, the Doppler ultrasonic segment had dominated the global ultrasound market leading to the growth of blood flow measurement devices and estimated to be growing at the same high pace during the forecast period.
Blood Flow Measurement Devices Market - By Application:
Based on application, in 2019, cardiovascular disease has contributed to the significant share of revenues to the world market among the non-invasive applications. It is likely to maintain the trend during the forecast period.
The CABG segment represented the largest share of the world market in 2019. The development of this segment can be attributed to a large number of CABG surgeries performed worldwide.
Presently, North America is leading the market by contributing the largest share of revenues in the given timeframe due to the growth of the geriatric population and the prevalence of the cardiovascular disease, the increased frequency of hypertension in the people and increased funding. Likewise, technological advancements and the increasing number of organ transplants to fuel the market for blood flow meters in North America.
Over the next few years, the market is likely to witness the maximum growth rate in the Asia-Pacific region owing to the increasing pervasiveness of non-communicable diseases, the rise in the geriatric population and the increasing attention of industry players in the area.
List of key market participants playing a leading role in the Global Blood Flow Measurement Devices Market profiled in the report are:
Recent Market Developments
On May 31, 2017, Deltex Medical Group Plc, has announced its new patent that has received acceptance which is a leader in Oesophageal Doppler Monitoring. The device filling covers the usage of Doppler measurements of blood flow, and that is measured using the oesophageal that is in co-occurrence with blood pressure signals. The Cardiaq-ODM is used in patients during the surgery to monitor and measure the blood flow. The ODM permits the doctors to step in quickly to do the changes in circulating blood volume.
On July 8, 2015, Compumedics Ltd. company has made a public statement that the brain blood-flow Doppler ultrasonography division, where the importance and impact can have in terms of business and trade and also economical.
On January 22, 2016, Medistim introduced a new product called MiraQ that is used for the intraoperative quality of cardiac, vascular and transplant surgery. This product is the fourth generation device of Medistim. This MiraQ integrates both the ultrasound imaging quality and blood flow measurement. The system is very malleable and accessible that allows customers for customer application.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Ultra Sound
22.214.171.124 Ultrasound Doppler
126.96.36.199 Transit-Time Flow Meters
5.1.3 Laser Doppler
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2.2 Non-Invasive Applications
188.8.131.52 Cardiovascular Disease
184.108.40.206 Tumour Monitoring
220.127.116.11 Other Non-Invasive Applications
5.2.3 Invasive Applications
18.104.22.168 Microvascular Surgery
22.214.171.124 Other Invasive Application
5.2.4 Y-o-Y Growth Analysis, By Application
5.2.5 Market Attractiveness Analysis, By Application
5.2.6 Market Share Analysis, By Application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Product
184.108.40.206 By Application
6.1.4 Market Attractiveness Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Product
22.214.171.124 By Application
6.1.5 Market Share Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Product
184.108.40.206 By Application
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Moor Instruments Ltd. (U.K.)
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Compumedics Ltd. (Australia)
8.3 Transonic Systems, Inc. (U.S.)
8.4 Cook Medical, Inc. (U.S.)
8.5 Perimed AB (Sweden)
8.6 Medistim ASA (Norway)
8.7 ADInstruments (Australia)
8.8 Deltex Medical Group plc (U.K.)
8.9 BIOPAC Systems, Inc. (U.S.)
8.10 Atys Medical (France)
8.11 SONOTEC Ultraschallsensorik Halle GmbH (Germany)
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures